MRNA vs NRIX · rev $145.0M vs rev $15.3M
Moderna Inc (MRNA) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported NRIX revenue for 2026-05-31 was $15.3M. Net income was -$176.7M. NRIX currently screens at market cap $1.77B.
MRNA currently screens at market cap $24.52B. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the MRNA and NRIX stock pages for the full models.
Not investment advice.